Ampicillin Sodium (A2510): Evidence-Based Mechanism & Antibacterial Benchmarks

Executive Summary: Ampicillin sodium (CAS 69-52-3) is a β-lactam antibiotic that competitively inhibits bacterial transpeptidase, thereby disrupting cell wall biosynthesis and provoking cell lysis (FEBS 1993). It demonstrates an IC50 of 1.8 μg/mL against E. coli 146 transpeptidase and a minimum inhibitory concentration (MIC) of 3.1 μg/mL in vitro (Kanamycin-Sulfate.com). The compound is highly water-soluble (≥18.57 mg/mL) and is validated for use in antibacterial activity assays and animal infection models (APExBIO). Stringent quality control includes NMR, MS, and COA documentation, with a supplied purity of 98%. The product is distributed by APExBIO and supports both Gram-positive and Gram-negative bacterial research.

Biological Rationale

Ampicillin sodium is a semi-synthetic derivative of penicillin developed to broaden the antibacterial spectrum to include both Gram-positive and Gram-negative organisms (GentamycinSulfate.com). The molecule’s β-lactam ring enables targeted inhibition of bacterial cell wall biosynthesis, a process critical for bacterial viability but absent in eukaryotic cells. This selectivity underpins its widespread use in both basic and translational research, particularly for evaluating the effects of cell wall disruption in bacterial models. APExBIO’s ampicillin sodium (A2510) is routinely employed for selection in recombinant DNA workflows, including in E. coli strains, due to its reliable activity and quantifiable benchmarks (FEBS 1993).

Mechanism of Action of Ampicillin Sodium

Ampicillin sodium’s primary mechanism is the irreversible inhibition of bacterial transpeptidase enzymes, also known as penicillin-binding proteins (PBPs). These enzymes catalyze the cross-linking of peptidoglycan layers during the final stages of bacterial cell wall biosynthesis. Ampicillin sodium covalently binds to the active site serine of the transpeptidase, preventing cross-link formation (Carbenicillin-Disodium-Salt.com). This results in weakened cell wall structure, increased osmotic sensitivity, and eventual bacterial cell lysis. The drug is effective against a broad spectrum of bacteria, including both Gram-positive species (e.g., Streptococcus pneumoniae) and Gram-negative species (e.g., Escherichia coli). The molecular target and action are conserved in most non-resistant bacterial strains, making it a standard in antibacterial assays and infection models.

Evidence & Benchmarks

• Ampicillin sodium exhibits an IC50 of 1.8 μg/mL against E. coli 146 transpeptidase at 37°C, pH 7.4 (source).
• The minimum inhibitory concentration (MIC) for E. coli is 3.1 μg/mL in standard LB medium conditions (product data).
• The compound is soluble in water at concentrations ≥18.57 mg/mL, in DMSO at ≥73.6 mg/mL, and in ethanol at ≥75.2 mg/mL (APExBIO COA).
• Ampicillin sodium achieves ≥98% purity by NMR and MS quality control, supporting reproducible assay results (product documentation).
• In recombinant protein workflows, such as for annexin V purification in E. coli, 50 μg/mL is a standard selection concentration (FEBS 1993).

Applications, Limits & Misconceptions

Ampicillin sodium is validated for use in antibacterial activity assays, antibiotic resistance research, and as a selective agent for plasmid maintenance in bacterial expression systems. Its defined IC50 and MIC values facilitate standardized performance across research laboratories. The compound is used in both in vitro (cell culture, plate assays) and in vivo (animal infection models) contexts (Chloramphenicol.co). This article extends prior mechanistic reviews by integrating up-to-date benchmarks and clarifying storage and handling parameters not detailed in linked resources.

Common Pitfalls or Misconceptions

• Not effective against β-lactamase-producing (resistant) bacterial strains; co-administration with β-lactamase inhibitors is required for such cases.
• Long-term storage of ampicillin sodium solutions at room temperature leads to rapid degradation; fresh solutions are recommended for each experiment.
• Not suitable for antifungal or antiviral applications, as its mechanism targets bacterial cell wall synthesis.
• Overuse in culture can select for resistant mutants, confounding experimental results.
• MIC values may vary with medium composition and bacterial strain; empirical validation under local conditions is essential.

Workflow Integration & Parameters

Ampicillin sodium (A2510) from APExBIO is supplied as a lyophilized powder with ≥98% purity, supported by NMR, MS, and COA data. For research use, the compound is dissolved in water (≥18.57 mg/mL) or DMSO (≥73.6 mg/mL). Stock solutions should be freshly prepared and kept at −20°C until use. The product is shipped on blue ice to ensure stability. In recombinant protein workflows, such as E. coli-based annexin V production, a typical working concentration is 50 μg/mL (FEBS 1993). For antibacterial activity assays, recommended MIC benchmarking should be performed in each laboratory setting. Compared to previous reviews that focus exclusively on the β-lactam mechanism, this article provides detailed integration parameters and empirical storage guidance.

Conclusion & Outlook

Ampicillin sodium remains a cornerstone of antibacterial research, providing a robust tool for cell wall biosynthesis inhibition, antibacterial activity assays, and the development of bacterial infection models. Its well-characterized mechanism, reproducible performance metrics, and compatibility with standard laboratory workflows make it indispensable for antibiotic resistance studies and recombinant protein selection. For high-purity, research-grade ampicillin sodium, APExBIO’s A2510 product offers validated performance and comprehensive quality control. For further mechanistic or translational context, see the update provided in GentamycinSulfate.com, which this article extends by providing direct evidence and practical parameters for modern workflows.